Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Psoriasis (approved 2022)
Alopecia Areata (Phase 2)
Arthritis, Psoriatic (Phase 3)
Autoimmune Diseases (Phase 1)
Colitis, Ulcerative (Phase 2)
Crohn Disease (Phase 2)
Glaucoma, Open-Angle (Phase 3)
Healthy Volunteers (Phase 1)
Hidradenitis Suppurativa (Phase 2)
Inflammatory Bowel Diseases (Phase 1)
Kidney Failure, Chronic (Phase 1)
Lichen Planus (Phase 2)
Liver Diseases (Phase 1)
Lupus Erythematosus, Cutaneous (Phase 2)
Lupus Erythematosus, Discoid (Phase 2)
Lupus Erythematosus, Systemic (Phase 3)
Lupus Nephritis (Phase 2)
Ocular Hypertension (Phase 3)
Psoriasis (Phase 4)
Pyoderma Gangrenosum (Early Phase 1)
Sjogren's Syndrome (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue